Dipna Pharmachem Ltd Allots 22,44,000 Equity Shares After Conversion of Warrants

Dipna Pharmachem Ltd, at its board meeting held on 29% November, 2025, considered and approved the allotment of 22,44,000 fully paid-up equity shares pursuant to the conversion of 22,44,000 convertible warrants. The warrants were allotted to Mr. Ashok Dilipkumar Jain and Ms. Kajal Ashok Jain, the allottees belonging to the ‘Non-Promoter Category’. The allotment was made at an issue price of Rs. 13.05/- each (including premium of Rs. 03.05/- each) on receipt of the balance amount, i.e., 75.00% of the issue price per warrant. The equity shares allotted upon the exercise of warrants on a preferential basis shall rank pari-passu with the existing equity shares of the Company in all respects. This has resulted in an increase in the paid-up equity share capital of the Company from Rs. 24,04,52,500.00/- to Rs. 26,28,92,500.00/-. The application for listing and trading approval of the newly issued and allotted equity shares will be made to the Stock Exchange in due course.